Innovation Field
Global Leading Technology
First-In-Class
Address Unmet Clinical Needs
Tumor-targeted fluorescent contrast agent is a new type of molecular imaging contrast agent, which can be specifically combined with tumors and accurately illuminate invisible residual malignant lesions intraoperatively via near-infrared imaging system.
Learn More
Real-time tumor assessment
Identification of tumor margins
Identification of clinically occult lesions
Location of positive lymph nodes
Identification of vital structures
The pipeline covers nearly 80% of solid tumors, impacts 3 million surgical procedures annually and more than 100 million endoscopic procedures.
Solid Tumors
Impact 3 million surgical procedures annually
More than 100 million endoscopic procedures
Prostate
Lung
Ovarian
Breast
Gastric
Colorectal
【Scan and follow us】
